SCHEMBL3944166

SCHEMBL3944166

CN1CCN(c2ccc(CNC(=O)c3n[nH]cc3-c3ccc(Cl)cc3Cl)cc2)CC1.CNS(=O)(=O)Cc1ccc(CNC(=O)c2n[nH]cc2-c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ACE2 Q9BYF1 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CNR2 P34972 2/20 0.41
RAB9A P51151 1/20 0.41
CNR1 P21554 1/20 0.41
TNIK Q9UKE5 1/20 0.40
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TP53 P04637 2/20 0.39
POLB P06746 2/20 0.39
KDR P35968 1/20 0.38
FLT3 P36888 1/20 0.38
KDM1A O60341 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL955230 0.92 ACE2 (0.48) GAAL3MBTL1ACE2KMT2AMAPT
SCHEMBL954495 0.89 CNR1 (0.42) L3MBTL1KMT2AMAPTCNR2CNR1
SCHEMBL16310085 0.77 TUBB (0.43) L3MBTL1KMT2AMAPTCNR2CNR1
SCHEMBL953774 0.75 ACE2 (0.53) ACE2KMT2AKDRFLT3KDM1A
SCHEMBL955617 0.73 ACE2 (0.48) ACE2KMT2AKDRFLT3KDM1A
SCHEMBL3945944 0.73 ACE2 (0.50) ACE2KMT2AKDRFLT3KDM1A
SCHEMBL3728268 0.72 MAPT (0.36) MAPTCNR1POLB
SCHEMBL5945710 0.72 CNR2 (0.54) GAAL3MBTL1ACE2KMT2ACNR2
SCHEMBL4441493 0.71 EGFR (0.49) GAAACE2KMT2AMAPTRAB9A
SCHEMBL954427 0.69 MAPT (0.55) GAAACE2KMT2AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046330-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
EP-2046327-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
WO-2008009954-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-24 WO disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed